Cargando…
Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies
Alzheimer’s disease (AD) is a multifactorial neurodegenerative condition of the central nervous system (CNS) that is currently treated by cholinesterase inhibitors and the N-methyl-d-aspartate receptor antagonist, memantine. Emerging evidence strongly supports the relevance of targeting butyrylcholi...
Autores principales: | Mamun, Abdullah Al, Pidaný, Filip, Hulcová, Daniela, Maříková, Jana, Kučera, Tomáš, Schmidt, Monika, Catapano, Maria Carmen, Hrabinová, Martina, Jun, Daniel, Múčková, Lubica, Kuneš, Jiří, Janoušek, Jiří, Andrýs, Rudolf, Nováková, Lucie, Peřinová, Rozálie, Maafi, Negar, Soukup, Ondřej, Korábečný, Jan, Cahlíková, Lucie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348983/ https://www.ncbi.nlm.nih.gov/pubmed/34361074 http://dx.doi.org/10.3390/ijms22158308 |
Ejemplares similares
-
Amaryllidaceae Alkaloids of Belladine-Type from Narcissus pseudonarcissus cv. Carlton as New Selective Inhibitors of Butyrylcholinesterase
por: Al Mamun, Abdullah, et al.
Publicado: (2020) -
Derivatives of the β-Crinane Amaryllidaceae Alkaloid Haemanthamine as Multi-Target Directed Ligands for Alzheimer’s Disease
por: Kohelová, Eliška, et al.
Publicado: (2019) -
Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer’s Disease
por: Cahlíková, Lucie, et al.
Publicado: (2021) -
Structure Elucidation and Cholinesterase Inhibition Activity of Two New Minor Amaryllidaceae Alkaloids
por: Maříková, Jana, et al.
Publicado: (2021) -
Semisynthetic Derivatives of Selected Amaryllidaceae Alkaloids as a New Class of Antimycobacterial Agents
por: Maafi, Negar, et al.
Publicado: (2021)